Here’s Who Just Picked Up Endologix Inc. (NASDAQ:ELGX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Endologix Inc. (NASDAQ:ELGX) reported that Brown Capital Management Llc. has picked up 8,755,102 of common stock as of 2017-03-07.
The acquisition brings the aggregate amount owned by Brown Capital Management Llc. to a total of 8,755,102 representing a 10.58% stake in the company.
For those not familiar with the company, Endologix, Inc. is engaged in developing, manufacturing, marketing and selling medical devices for the treatment of aortic disorders. The Company’s products are intended for the treatment of abdominal aortic aneurysms (AAA). The AAA products are built on one of two platforms, including traditional minimally invasive endovascular repair (EVAR) or endovascular sealing (EVAS), its solution for sealing the aneurysm sac while maintaining blood flow through two blood flow lumens. The EVAR products include the Endologix AFX Endovascular AAA System (AFX), the VELA Proximal Endograft (VELA) and the Endologix Powerlink with Intuitrak Delivery System (Intuitrak). The EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). Its EVAS product is the Nellix EndoVascular Aneurysm Sealing System (Nellix EVAS System). It offers accessories to facilitate the optimal delivery of its EVAR products, including compatible guidewires, snares, and catheter introducer sheaths.
A glance at Endologix Inc. (NASDAQ:ELGX)’s key stats reveals a current market capitalization of 519.30 Million based on 82.93 Million shares outstanding and a price at last close of $6.54 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-14, Zenty picked up 3,000 at a purchase price of $6.51. This brings their total holding to 41,574 as of the date of the filing.
On the sell side, the most recent transaction saw Lima unload 4,710 shares at a sale price of $11.68. This brings their total holding to 37,884.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Endologix Inc. (NASDAQ:ELGX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Just Picked Up Parker Drilling Co (NYSE:PKD) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Parker Drilling Co (NYSE:PKD) reported that Highbridge Capital Management has picked up 10,351,974 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Highbridge Capital Management to a total of 10,351,974 representing a 7.01% stake in the company.
For those not familiar with the company, Parker Drilling Company (Parker Drilling) is a provider of contract drilling, and drilling-related services and rental tools. The Company’s business consists of two business lines: drilling services and rental tools services. Its Rental Tools Services business includes its Rental Tools segment, and its Drilling Services business includes its U.S. (Lower 48) Drilling, and International & Alaska Drilling segments. The Company’s U.S. (Lower 48) Drilling segment provides drilling services with its Gulf of Mexico barge drilling rig fleet and through U.S. (Lower 48) based O&M services. Its International & Alaska Drilling segment provides drilling services, with Company-owned rigs, as well as through O&M contracts, and project related services. In its Rental Tools Services business, it provides rental equipment and services to exploration and production (E&P) companies, drilling contractors and service companies on land and offshore in the United States and select international markets.
A glance at Parker Drilling Co (NYSE:PKD)’s key stats reveals a current market capitalization of 225.73 million based on 125.23 Million shares outstanding and a price at last close of $1.85 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2017-02-24, Fontana picked up 160,000 at a purchase price of $1.90. This brings their total holding to 168,021 as of the date of the filing.
On the sell side, the most recent transaction saw Agnew unload 18,387 shares at a sale price of $2.80. This brings their total holding to 196,377.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Parker Drilling Co (NYSE:PKD) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Entellus Medical Inc. (NASDAQ:ENTL) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Entellus Medical Inc. (NASDAQ:ENTL) reported that Discovery Group I, Llc. has picked up 1,418,715 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Discovery Group I, Llc. to a total of 1,418,715 representing a 6.5% stake in the company.
For those not familiar with the company, Entellus Medical, Inc. is a medical technology company. The Company is focused on the design, development and commercialization of products for the minimally invasive treatment of patients who are suffering from chronic sinusitis. The Company’s XprESS family of products is used by ear, nose and throat (ENT) physicians to treat patients with symptomatic inflammation of the nasal sinuses by opening narrowed or obstructed sinus drainage pathways using balloon sinus dilation. The Company’s XprESS family of products is used to treat patients with inflammation of the frontal, ethmoid, sphenoid and maxillary sinuses. Its XprESS Multi-Sinus Dilation family of products consists of its XprESS Pro device, its XprESS LoProfile device and its XprESS Ultra device. The Company’s PathAssist tools provide ENT physicians with a way to confirm sinus location and XprESS device placement. Its FocESS Sinuscopes provide ENT physicians with a solution for endoscopic visualization during a sinus procedure.
A glance at Entellus Medical Inc. (NASDAQ:ENTL)’s key stats reveals a current market capitalization of 286.30 million based on 21.88 Million shares outstanding and a price at last close of $13.32 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2015-02-03, Split picked up 352,941 at a purchase price of $17.00. This brings their total holding to 3,156,731 as of the date of the filing.
On the sell side, the most recent transaction saw Essex unload 16,521 shares at a sale price of $17.00. This brings their total holding to 91,808.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Entellus Medical Inc. (NASDAQ:ENTL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Ashford Hospitality Prime Inc. (CVE:AHP) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Ashford Hospitality Prime Inc. (CVE:AHP) reported that Raging Capital Management has picked up 3,161,180 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Raging Capital Management to a total of 3,161,180 representing a 4.2% stake in the company.
For those not familiar with the company, Ashford Hospitality Prime, Inc. invests in high revenue per available room (RevPAR), luxury, upper-upscale and upscale hotels in gateway and resort locations. The Company conducts its business and owns all of its assets through its operating partnership, Ashford Hospitality Prime Limited Partnership. It operates in the direct hotel investment segment of the hotel lodging industry. It owns interest in over 15 hotels in approximately six states, the District of Columbia and St. Thomas, the United States Virgin Islands with over 3,950 total rooms, excluding those attributable to its partner. The hotels in its portfolio are located in the United States gateway and resort locations. The Company owns over 10 of its hotel properties directly, and the remaining hotel properties through an investment in a majority-owned consolidated entity. All of the hotels in the Company’s portfolio are asset-managed by Ashford Hospitality Advisors LLC.
A glance at Ashford Hospitality Prime Inc. (CVE:AHP)’s key stats reveals a current market capitalization of 287.49 million based on 26.03 Million shares outstanding and a price at last close of $11.05 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-06-06, Rinaldi picked up 800 at a purchase price of $16.87. This brings their total holding to 8,000 as of the date of the filing.
On the sell side, the most recent transaction saw Kessler unload 2,441 shares at a sale price of $15.00. This brings their total holding to 101,294.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Ashford Hospitality Prime Inc. (CVE:AHP) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Cpmg Inc. Picked Up Reata Pharmaceuticals Inc. (NASDAQ:RETA) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Reata Pharmaceuticals Inc. (NASDAQ:RETA) reported that Cpmg Inc. has picked up 3,161,180 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Cpmg Inc. to a total of 3,161,180 representing a 20.9% stake in the company.
For those not familiar with the company, Reata Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on identifying, developing and commercializing product candidates that modulate the activity of regulatory proteins involved in the biology of mitochondrial function, oxidative stress, and inflammation to address the unmet medical needs of patients with a range of serious or life-threatening diseases. The Company’s lead product candidates include bardoxolone methyl, which is being studied in Phase III trial for the treatment of pulmonary arterial hypertension (PAH), associated with connective tissue disease (CTD-PAH), as well as a Phase II trial for the treatment of pulmonary hypertension due to interstitial lung disease (PH-ILD), and PAH, each of which are subsets of pulmonary hypertension (PH), Omaveloxolone, which is in Phase II clinical development for the treatment of multiple diseases, including Friedreich’s ataxia, mitochondrial myopathies and metastatic melanoma.
A glance at Reata Pharmaceuticals Inc. (NASDAQ:RETA)’s key stats reveals a current market capitalization of 659.60 million based on 22.34 Million shares outstanding and a price at last close of $28.14 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-30, Traweek picked up 9,392 at a purchase price of $21.72. This brings their total holding to 1,926,034 as of the date of the filing.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Reata Pharmaceuticals Inc. (NASDAQ:RETA) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Guess Who Picked Up Optimizerx Corp (OTCMKTS:OPRX) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Optimizerx Corp (OTCMKTS:OPRX) reported that Wolverine Asset Management Llc. has picked up 2,155,860 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Wolverine Asset Management Llc. to a total of 2,155,860 representing a 7.3% stake in the company.
For those not familiar with the company, OptimizeRx Corporation is a technology solutions company. The Company focuses on the healthcare industry. The Company connects patients, physicians and pharmaceutical manufacturers through technology. The Company’s solutions provide pharmaceutical manufacturers a direct to physician channel for communicating and promoting products. It provides healthcare providers a means to provide sampling and coupons without having to physically store samples on site. The Company’s principal products and applications include SampleMD, OPTIMIZEHR and OPTIMIZERx.com. SampleMD is a virtual Patient Support Center. OPTIMIZEHR is a consulting practice focused on educating and working with pharmaceutical manufacturers on identifying, formulating and implementing new electronic prescribing (eRx) media strategies for promoting their products. OPTIMIZERx.com is a portal to healthcare savings for patients to centrally review and participate in prescription and healthcare savings and support programs.
A glance at Optimizerx Corp (OTCMKTS:OPRX)’s key stats reveals a current market capitalization of 23.84 million based on 29.67 Million shares outstanding and a price at last close of $0.750 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-12-13, Pinney picked up 4,000 at a purchase price of $0.80. This brings their total holding to 781,079 as of the date of the filing.
On the sell side, the most recent transaction saw Radoff unload 631,100 shares at a sale price of $1.41. This brings their total holding to 2,289,200.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Optimizerx Corp (OTCMKTS:OPRX) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Here’s Who Just Picked Up Bok Financial Corp Et Al (NASDAQ:BOKF) Shares
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Bok Financial Corp Et Al (NASDAQ:BOKF) reported that George Kaiser Family Foundation has picked up 2,714,286 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by George Kaiser Family Foundation to a total of 2,714,286 representing a 4.14% stake in the company.
For those not familiar with the company, BOK Financial Corporation is a financial holding company. The Company offers full service banking in Oklahoma, Texas, New Mexico, Colorado, Arizona and Kansas/Missouri. Its segments include Commercial Banking, Consumer Banking, Wealth Management, and Funds Management and Other. The Commercial Banking segment includes lending, treasury and cash management services, and customer risk management products for small businesses, middle market and commercial customers. The Consumer Banking segment includes retail lending and deposit services, lending and deposit services to small business customers served through the retail branch network and all mortgage banking activities. The Wealth Management segment provides fiduciary services, private bank services and investment advisory services in all markets; underwrites state and municipal securities, and engages in brokerage and trading activities. The Funds Management unit manages overall liquidity needs and interest rate risk.
A glance at Bok Financial Corp Et Al (NASDAQ:BOKF)’s key stats reveals a current market capitalization of 5.48 billion based on 65.49 Million shares outstanding and a price at last close of $83.20 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2014-09-04, Walker picked up 3,650 at a purchase price of $67.88. This brings their total holding to 3,670 as of the date of the filing.
On the sell side, the most recent transaction saw Nell unload 333 shares at a sale price of $83.30. This brings their total holding to 0.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Bok Financial Corp Et Al (NASDAQ:BOKF) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.
Whiting Petroleum Corp (NYSE:WLL) is Attracting Smart Money
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Whiting Petroleum Corp (NYSE:WLL) reported that Senator Investment Group has picked up 21,500,000 of common stock as of 2017-03-06.
The acquisition brings the aggregate amount owned by Senator Investment Group to a total of 21,500,000 representing a 5.93% stake in the company.
For those not familiar with the company, Whiting Petroleum Corporation is an independent oil and gas company. The Company is engaged in development, production, acquisition and exploration activities primarily in the Rocky Mountains and Permian Basin regions of the United States. The Company operates in the segment of exploration and production of crude oil, natural gas liquid (NGLs) and natural gas. The Company’s estimated proved reserves totaled approximately 820.6 Million Barrels of Oil Equivalent (MMBOE). The Company has interests in approximately 5,889 gross (3,177 net) productive wells on approximately 948,600 gross (593,900 net) developed acres across all its geographical areas. The Company’s Rocky Mountains operations include assets in the states of Colorado, Montana and North Dakota. The Company’s Permian Basin operations include its North Ward Estes field in the Ward and Winkler counties of Texas. Its other operations primarily relate to non-core assets in Colorado, Mississippi, North Dakota, Texas and Wyoming.
A glance at Whiting Petroleum Corp (NYSE:WLL)’s key stats reveals a current market capitalization of 3.88 billion based on 362.70 Million shares outstanding and a price at last close of $10.70 per share.
Looking at insider activity, there are a few transactions worth noting.
Specifically, on 2016-05-03, Volker picked up 10,000 at a purchase price of $10.30. This brings their total holding to 629,514 as of the date of the filing.
On the sell side, the most recent transaction saw Peterson unload 4,928 shares at a sale price of $19.67. This brings their total holding to 658,882.
It’s possible to gauge a company’s potential by tracking the activity of its major holders, as well as checking in on insider activity such as those transactions listed above. We’ll be keeping an eye on Whiting Petroleum Corp (NYSE:WLL) as things move forward to see if its progress aligns with these transactions.
Subscribe below and we’ll keep you on top of what’s happening before it moves markets.